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Background: Plaque rupture is the main mechanism implicated in the pathogenesis of acute coronary syndromes (ACS). There are no in vivo 
studies regarding the relationship between clinical type of ACS and plaque morphology. Optical coherence tomography (OCT) can discriminate 
between microstructures of vulnerable plaque in vivo. We assessed the morphological differences of ruptured plaques between patients (pts) with 
non-ST elevation ACS (NSTEACS) and pts with ST elevation myocardial infarction (STEMI).
Methods: Thirty patients with NSTEACS and 32 pts with STEMI were initially enrolled. Coronary angiography and subsequent OCT study of the culprit 
lesion were performed within 24 hours from symptom onset in NSTEACS patients and immediately before primary angioplasty in STEMI patients. 
Patients in whom plaque rupture was not identified by OCT were excluded from the study. Plaque rupture was defined as fibrous cap disruption with 
cavity formation.
Results: A rupture was identified in 19 pts with NSTEACS and in 23 pts with STEMI, and these patients comprised the study population. Patients 
with NSTEACS had shorter length of plaque disruption than patients with STEMI (1.56±0.78mm vs. 2.99±1.92 mm, p=0.005). Minimum fibrous 
cap thickness was similar between the two groups (49±26 vs. 45±19μm, p=0.57). Although cross-sectional area (CSA) of minimal lumen site was 
greater in pts with NSTEACS vs. STEMI (2.78±2.05mm2 vs. 1.31±0.85mm2, p=0.002), no differences were found in the CSA of the rupture site 
(4.69±2.76mm2 vs. 3.74±2.4 mm2, p=NS). No significant differences were found regarding the distance of the rupture from the minimal lumen 
site (2.29±1.89mm vs. 2.90±2.64 mm, p=NS) and the incidence of plaques broken at cap shoulder (73.7% vs. 69.5%, p=NS). The length of missing 
fibrous cap was greater in pts with STEMI compared to pts with NSTEACS (0.62±0.31 vs. 0.43±0.17mm, p<0.05).
Conclusions: Ruptured plaques of patients with STEMI have greater rupture length and greater length of missing fibrous cap than patients with 
NSTEACS. In vivo morphological differences between clinical types of ACS could shed more light to the mechanisms responsible for clinical onset of 
ACS.
